Your browser doesn't support javascript.
loading
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
Havla, Joachim; Pakeerathan, Thivya; Schwake, Carolin; Bennett, Jeffrey L; Kleiter, Ingo; Felipe-Rucián, Ana; Joachim, Stephanie C; Lotz-Havla, Amelie S; Kümpfel, Tania; Krumbholz, Markus; Wendel, Eva M; Reindl, Markus; Thiels, Charlotte; Lücke, Thomas; Hellwig, Kerstin; Gold, Ralf; Rostasy, Kevin; Ayzenberg, Ilya.
Afiliação
  • Havla J; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians Universität München, Munich, Germany. joachim.havla@med.lmu.de.
  • Pakeerathan T; Data Integration for Future Medicine (DIFUTURE) Consortium, LMU Hospital, Ludwig-Maximilians Universität München, Munich, Germany. joachim.havla@med.lmu.de.
  • Schwake C; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Bennett JL; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Kleiter I; Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado Anschutz Medical Campus, Denver, USA.
  • Felipe-Rucián A; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Joachim SC; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany.
  • Lotz-Havla AS; Department of Pediatric Neurology, Vall d'Hebron Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Kümpfel T; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Krumbholz M; Dr. von Hauner Children's Hospital, LMU Hospital, Ludwig-Maximilians Universität München, Munich, Germany.
  • Wendel EM; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians Universität München, Munich, Germany.
  • Reindl M; Department of Neurology & Stroke and Hertie Institute for Clinical Brain Research, University Hospital of Tübingen, Tübingen, Germany.
  • Thiels C; Department of Pediatric Neurology, Olgaspital Stuttgart, Stuttgart, Germany.
  • Lücke T; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Hellwig K; Department of Neuropaediatrics and Social Pediatrics, University Hospital of Pediatrics and Adolescent Medicine, Ruhr-University, Bochum, Germany.
  • Gold R; Department of Neuropaediatrics and Social Pediatrics, University Hospital of Pediatrics and Adolescent Medicine, Ruhr-University, Bochum, Germany.
  • Rostasy K; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Ayzenberg I; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
J Neuroinflammation ; 18(1): 121, 2021 May 29.
Article em En | MEDLINE | ID: mdl-34051804
ABSTRACT

BACKGROUND:

To investigate age-related severity, patterns of retinal structural damage, and functional visual recovery in pediatric and adult cohorts of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) optic neuritis (ON).

METHODS:

All MOGAD patients from the 5 participating centers were included. Patients with initial manifestation <18 years were included in the pediatric (MOGADped) cohort and patients with ≥18 years in the adult (MOGADadult) cohort. For patients with MOGAD ON, examinations at least ≥6 months after ON onset were included in the analyses. Using spectral domain optical coherence tomography (SD-OCT), we acquired peripapillary retinal nerve fiber layer thickness (pRNFL) and volumes of combined ganglion cell and inner plexiform layer (GCIPL). High- and 2.5% low-contrast visual acuity (HCVA, LCVA) and visual-evoked potentials (VEP) were obtained.

RESULTS:

Twenty MOGADped (10.3±3.7 years, 30 MOGAD ON eyes) and 39 MOGADadult (34.9±11.6 years, 42 MOGAD ON eyes) patients were included. The average number of ON episodes per ON eye was similar in both groups (1.8±1.3 and 2.0±1.7). In both pediatric and adult MOGAD, ON led to pronounced neuroaxonal retinal atrophy (pRNFL 63.1±18.7 and 64.3±22.9 µm; GCIPL 0.42±0.09 and 0.44±0.13 mm3, respectively) and moderate delay of the VEP latencies (117.9±10.7 and 118.0±14.5 ms). In contrast, visual acuity was substantially better in children (HCVA 51.4±9.3 vs. 35.0±20.6 raw letters, p=0.001; LCVA 22.8±14.6 vs. 13.5±16.4, p=0.028). Complete visual recovery (HCVA-logMAR 0.0) occurred in 73.3% of MOGADped and 31% MOGADadults ON eyes, while 3.3% and 31% demonstrated moderate to severe (logMAR > 0.5) visual impairment. Independent of retinal atrophy, age at ON onset significantly correlated with visual outcome.

CONCLUSION:

Pediatric MOGAD ON showed better visual recovery than adult MOGAD ON despite profound and almost identical neuroaxonal retinal atrophy. Age-related cortical neuroplasticity may account for the substantial discrepancy between structural changes and functional outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retina / Transtornos da Visão / Acuidade Visual / Neurite Óptica / Doenças Autoimunes do Sistema Nervoso Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retina / Transtornos da Visão / Acuidade Visual / Neurite Óptica / Doenças Autoimunes do Sistema Nervoso Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha